Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. (Q45050683)
Jump to navigation
Jump to search
scientific article published in September 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. |
scientific article published in September 2004 |
Statements
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide (English)
Carme Valls
Sergi Cabré
Francis De Zegher